The largest study to investigate the role of inflammatory biomarkers in hospitalized COVID-19 patients uncovers risk factors for worse health outcomes in those with diabetes.
In type 1 diabetes, new research identifies critical ways to improve blood sugar management across different demographic groups.
A novel therapeutic may halt rapid kidney function in some type 1 diabetic kidney disease patients.
Lowering blood sugar levels and shedding weight can help combat diabetes complications, but researchers say this “one size fit all” approach ignores other risk factors.
Preliminary observations of COVID-19 patients with diabetes inspired an algorithm for glucose monitoring that’s suspected to help combat the virus’ serious complications.
A physician-scientist explains his latest research in the area.